Literature DB >> 15473063

Intravitreal injection of vascular endothelial growth factor small interfering RNA inhibits growth and leakage in a nonhuman primate, laser-induced model of choroidal neovascularization.

Michael J Tolentino, Alexander J Brucker, Joshua Fosnot, Gui-shuang Ying, I-Hui Wu, Gulraiz Malik, Shanhong Wan, Samuel J Reich.   

Abstract

Entities:  

Year:  2004        PMID: 15473063     DOI: 10.1097/00006982-200408000-00039

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


× No keyword cloud information.
  13 in total

Review 1.  Animal models of age related macular degeneration.

Authors:  Mark E Pennesi; Martha Neuringer; Robert J Courtney
Journal:  Mol Aspects Med       Date:  2012-06-15

2.  Preclinical Mammalian Safety Studies of EPHARNA (DOPC Nanoliposomal EphA2-Targeted siRNA).

Authors:  Michael J Wagner; Rahul Mitra; Mark J McArthur; Wallace Baze; Kirstin Barnhart; Sherry Y Wu; Cristian Rodriguez-Aguayo; Xinna Zhang; Robert L Coleman; Gabriel Lopez-Berestein; Anil K Sood
Journal:  Mol Cancer Ther       Date:  2017-03-06       Impact factor: 6.261

Review 3.  Brothers in arms: DNA enzymes, short interfering RNA, and the emerging wave of small-molecule nucleic acid-based gene-silencing strategies.

Authors:  Ravinay Bhindi; Roger G Fahmy; Harry C Lowe; Colin N Chesterman; Crispin R Dass; Murray J Cairns; Edward G Saravolac; Lun-Quan Sun; Levon M Khachigian
Journal:  Am J Pathol       Date:  2007-08-23       Impact factor: 4.307

Review 4.  Small-interfering RNAs (siRNAs) as a promising tool for ocular therapy.

Authors:  A Guzman-Aranguez; P Loma; J Pintor
Journal:  Br J Pharmacol       Date:  2013-10       Impact factor: 8.739

5.  Age-related macular degeneration: experimental and emerging treatments.

Authors:  Jean Pierre Hubschman; Shantan Reddy; Steven D Schwartz
Journal:  Clin Ophthalmol       Date:  2009-06-02

Review 6.  Nonviral methods for siRNA delivery.

Authors:  Kun Gao; Leaf Huang
Journal:  Mol Pharm       Date:  2009 May-Jun       Impact factor: 4.939

7.  Antivascular endothelial growth factor agents for neovascular age-related macular degeneration.

Authors:  Ilias Zampros; Anna Praidou; Periklis Brazitikos; Panagiotis Ekonomidis; Sofia Androudi
Journal:  J Ophthalmol       Date:  2011-11-19       Impact factor: 1.909

8.  Inhibition of VEGF expression and corneal neovascularization by shRNA targeting HIF-1α in a mouse model of closed eye contact lens wear.

Authors:  Peng Chen; Hongmei Yin; Ye Wang; Yao Wang; Lixin Xie
Journal:  Mol Vis       Date:  2012-04-06       Impact factor: 2.367

Review 9.  Lipid nanoparticles for short interfering RNA delivery.

Authors:  Alex K K Leung; Yuen Yi C Tam; Pieter R Cullis
Journal:  Adv Genet       Date:  2014       Impact factor: 1.944

10.  Bevasiranib for the treatment of wet, age-related macular degeneration.

Authors:  Adinoyi O Garba; Shaker A Mousa
Journal:  Ophthalmol Eye Dis       Date:  2010-12-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.